title: Relationship between preoperative serum CA 15-3 and CEA levels and clinicopathological parameters in breast cancer.
abstract: BACKGROUND
  CEA and CA 15.3 serum tumor markers are currently used in clinical practice for monitoring therapy. The aim of this study was to evaluate serum level of these markers among healthy females and invasive breast carcinoma (IBC) patients and to determine any relationships with clinicopathological factors.
  
  
  METHODS
  60 Iranian females were enrolled in this study, 30 healthy and 30 diagnosed with breast cancer who had not received any preoperative chemotherapy or hormone therapy. Enzyme linked immunosorbent assays were used for the quantitative determination of the cancer associated antigens, CEA and MUC1 (CA 15- 3).
  
  
  RESULTS
  The serological levels of CEA and CA 15-3 (5.0033 ± 0.49 μg/L and 178.1667 ± 15.11 U/ml) in the breast cancer patients were significantly higher (p=0.00) than the serum levels of normal controls (1.1237 ± 0.11 μg/L and 21.13 ± 3.058 U/ml). Regarding the CEA marker, a significant correlation with grade of tumor was shown. Furthermore, there was a low correlation between CA 15-3 and CEA marker with correlation coefficient r=0.08.
  
  
  CONCLUSIONS
  Collectively, markedly high levels of CEA and CA 15-3 were found in our patients, pointing to their use as additional tools after clinical diagnosis.
authors.affiliation: Department of Molecular Biology, Pasteur Institute of Iran, Tehran E-mail : manaoloomi@yahoo.com.
authors.forename: Neda
authors.initials: N
authors.lastname: Moazzezy
authors.forename: Tahereh Zarnoosheh
authors.initials: TZ
authors.lastname: Farahany
authors.forename: Mana
authors.initials: M
authors.lastname: Oloomi
authors.forename: Saeid
authors.initials: S
authors.lastname: Bouzari
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000097:blood*; D018270:Carcinoma, Ductal, Breast / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D018275:Carcinoma, Lobular / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D005260:Female; D006801:Humans; D007492:Iran; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D055815:Young Adult
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D018396:Mucin-1